Total Payments
$18,580
2024 Payments
$3,316
Companies
23
Transactions
388
Medicare Patients
1,237
Medicare Billing
$298,004
Payment Breakdown by Category
Food & Beverage$13,449 (72.4%)
Travel$3,553 (19.1%)
Consulting$1,190 (6.4%)
Education$373.57 (2.0%)
Other$14.98 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,449 | 366 | 72.4% |
| Travel and Lodging | $3,553 | 16 | 19.1% |
| Consulting Fee | $1,190 | 1 | 6.4% |
| Education | $373.57 | 4 | 2.0% |
| Grant | $14.98 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,868 | 56 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,231 | 28 | $0 (2019) |
| Alnylam Pharmaceuticals Inc. | $1,730 | 13 | $0 (2024) |
| ABIOMED | $1,586 | 12 | $0 (2024) |
| Amgen Inc. | $1,528 | 52 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,194 | 54 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $593.98 | 24 | $0 (2019) |
| PFIZER INC. | $572.05 | 38 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $457.01 | 22 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $408.45 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,316 | 22 | Alnylam Pharmaceuticals Inc. ($1,349) |
| 2023 | $1,373 | 18 | Abbott Laboratories ($638.32) |
| 2022 | $990.46 | 20 | ABIOMED ($398.90) |
| 2021 | $1,552 | 22 | Abbott Laboratories ($771.78) |
| 2020 | $95.13 | 4 | Novartis Pharmaceuticals Corporation ($47.34) |
| 2019 | $3,059 | 67 | Abbott Laboratories ($1,237) |
| 2018 | $5,381 | 121 | Abbott Laboratories ($2,131) |
| 2017 | $2,814 | 114 | Amgen Inc. ($472.99) |
All Payment Transactions
388 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $147.87 | General |
| Category: Heart Failure | ||||||
| 11/06/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $46.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 09/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $135.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $191.55 | General |
| Category: Heart Failure | ||||||
| 09/09/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $170.91 | General |
| Category: Heart Failure | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $26.65 | General |
| 08/29/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $100.83 | General |
| Category: Heart Failure | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: DIABETES | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.34 | General |
| 06/27/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $334.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $227.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $121.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Heart Failure | ||||||
| 05/14/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $50.33 | General |
| Category: Cardiology | ||||||
| 04/02/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Heart Failure | ||||||
| 03/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.65 | General |
| 02/28/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $180.43 | General |
| Category: Heart Failure | ||||||
| 02/01/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $124.36 | General |
| Category: Genetic Disease | ||||||
| 01/18/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,190.00 | General |
| Category: Genetic Disease | ||||||
| 12/23/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $113.43 | General |
| Category: Heart Failure | ||||||
| 12/15/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: Heart Failure | ||||||
| 12/04/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 337 | 660 | $329,246 | $77,273 |
| 2022 | 8 | 384 | 755 | $376,115 | $87,130 |
| 2021 | 8 | 405 | 941 | $427,327 | $108,653 |
| 2020 | 6 | 111 | 270 | $98,395 | $24,947 |
Total Patients
1,237
Total Services
2,626
Medicare Billing
$298,004
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 122 | 369 | $143,318 | $39,713 | 27.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 79 | $81,885 | $15,753 | 19.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 77 | 83 | $62,057 | $13,104 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 64 | 88 | $36,168 | $7,112 | 19.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 19 | $5,114 | $1,427 | 27.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 22 | 22 | $704.00 | $164.56 | 23.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 116 | 352 | $135,100 | $33,808 | 25.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 116 | $119,736 | $24,043 | 20.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 84 | 90 | $66,728 | $16,542 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 52 | 82 | $33,702 | $7,258 | 21.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $7,420 | $1,935 | 26.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 23 | 24 | $6,208 | $1,618 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 23 | $5,525 | $1,530 | 27.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 45 | 53 | $1,696 | $396.00 | 23.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 61 | 214 | $192,832 | $44,184 | 22.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 106 | 347 | $124,618 | $33,096 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 63 | 180 | $38,503 | $12,107 | 31.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 51 | 54 | $22,796 | $6,901 | 30.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 30 | 31 | $20,332 | $5,632 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 57 | $23,379 | $5,393 | 23.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 15 | $3,330 | $1,005 | 30.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 37 | 43 | $1,537 | $334.11 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 39 | 170 | $36,110 | $11,526 | 31.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 16 | 42 | $36,535 | $8,820 | 24.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 25 | $10,000 | $3,273 | 32.7% |
About Dr. Shudhanshu Alishetti, M.D
Dr. Shudhanshu Alishetti, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1821431040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shudhanshu Alishetti, M.D has received a total of $18,580 in payments from pharmaceutical and medical device companies, with $3,316 received in 2024. These payments were reported across 388 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($13,449).
As a Medicare-enrolled provider, Alishetti has provided services to 1,237 Medicare beneficiaries, totaling 2,626 services with total Medicare billing of $298,004. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology
- Location Brooklyn, NY
- Active Since 04/08/2013
- Last Updated 08/30/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1821431040
Products in Payments
- Impella (Device) $1,586
- AMVUTTRA (Drug) $1,453
- CardioMEMS HF System (Device) $1,253
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,081
- No Associated Abbott Product (Device) $1,038
- BRILINTA (Drug) $976.27
- ELIQUIS (Drug) $851.12
- Repatha (Biological) $781.97
- Corlanor (Drug) $660.81
- PRALUENT ALIROCUMAB INJECTION (Biological) $540.14
- CARDIOMEMS (Device) $457.78
- HeartMate 3 Left Ventricular Assist Device (Device) $452.04
- ENTRESTO (Drug) $408.45
- AccuCinch (Device) $388.00
- LifeVest (Device) $294.40
- PRALUENT (Drug) $291.16
- ONPATTRO (Drug) $276.90
- KENGREAL (Drug) $239.29
- WATCHMAN (Device) $236.66
- JARDIANCE (Drug) $208.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799